Cargando…
Assessing the feasibility of Phase 3 vaccine trials against Marburg Virus Disease: A modelling study
BACKGROUND: Outbreaks of Marburg virus disease (MVD) are rare and small in size, with only 18 recorded outbreaks since 1967, only two of which involved more than 100 cases. It has been proposed, therefore, that Phase 3 trials for MVD vaccines should be held open over multiple outbreaks until suffici...
Autores principales: | Qian, George Y., Jombart, Thibaut, John Edmunds, W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10318427/ https://www.ncbi.nlm.nih.gov/pubmed/37409192 http://dx.doi.org/10.1016/j.jvacx.2023.100321 |
Ejemplares similares
-
A mathematical model of Marburg virus disease outbreaks and the potential role of vaccination in control
por: Qian, George Y., et al.
Publicado: (2023) -
Ebola and Marburg virus vaccines
por: Reynolds, Pierce, et al.
Publicado: (2017) -
Immune correlates of postexposure vaccine protection against Marburg virus
por: Woolsey, Courtney, et al.
Publicado: (2020) -
Analysis of global routine immunisation coverage shows disruption and stagnation during the first two-years of the COVID-19 pandemic with tentative recovery in 2022
por: Evans, Beth, et al.
Publicado: (2023) -
A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats
por: Longini, Ira M, et al.
Publicado: (2022)